Sutrobio.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
61% 
Page quality
79% 
Page structure
70% 
Link structure
92% 
Server
87% 
External factors
100% 
SEO Score
Response time
2.59 s
File size
157.60 kB
Words
504
Media files
5
Number of links
45 internal / 19 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company.
The page title should be shorter than 580 pixels. It is 1262 pixels long. Optimize title
There are no duplicate words in the title
Meta description
(Critically important)
Sutro Biopharma, Inc. is a public biotechnology company headquartered in South San Francisco, California focused on clinical stage drug discovery, development and manufacturing company. Using its integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics for cancer and autoimmune disorders. It focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (I/O) therapeutics, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed primarily against clinically validated targets. Its product candidates include STRO-001 and STRO-002. STRO-001 is an ADC directed against the cancer target CD74, for patients with multiple myeloma and non-Hodgkin lymphoma (NHL). STRO-002 is an ADC directed against folate receptor-alpha (FolRa), for patients with ovarian and endometrial cancers. STRO-001 and STRO-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody using its XpressCF platform.
The meta description is too long: 6555 pixels from max. 1000 pixels. Optimize description
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.sutrobio.com/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en-us
Server location: United States of America
The following language is defined by HTML: en-us
Alternate/Hreflang Links
(Somewhat important)
There are no alternate links specified on this page.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
descriptionSutro Biopharma, Inc. is a public biotechnology company headquartered in South San Francisco, California focused on clinical stage drug discovery, development and manufacturing company. Using its integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics for cancer and autoimmune disorders. It focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (I/O) therapeutics, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed primarily against clinically validated targets. Its product candidates include STRO-001 and STRO-002. STRO-001 is an ADC directed against the cancer target CD74, for patients with multiple myeloma and non-Hodgkin lymphoma (NHL). STRO-002 is an ADC directed against folate receptor-alpha (FolRa), for patients with ovarian and endometrial cancers. STRO-001 and STRO-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody using its XpressCF platform.
keywordsBiotechnology, biopharm, biopharma, cancer, oncology, South San Francisco, Sutro, SSF, clinical stage drug discovery, cell-free protein synthesis, XpressCF platform, STRO-001, STRO-002, cancer, autoimmune disorders, cytokine based imunno-oncology, (I/O), antibody drug-conjugates (ADC), ADCs, ADC, I/O, bispecific antibodies, STRO-001, STRO-002, CD74, multiple myeloma, non-Hodgkin lymphoma, NHL, folate receptor alpha, FOLRa, ovarian cancer, endometrial cancer, linker warheads, linker, war heads, XpressCF platform, biotech
robotsmax-image-preview:large
generatorPowered by WPBakery Page Builder - drag and drop page builder for WordPress.
viewportwidth=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0
msapplication-TileImagehttps://www.sutrobio.com/wp-content/uploads/2020/03/cropped-sutro-icon-500x500-1-270x270.png
langen-us
X-UA-CompatibleIE=edge
charsetUTF-8

Automatically check sutrobio.com including all subpages at once!

Try for free
Guaranteed free of charge during trial period.

Page quality

Content
(Critically important)
Some words from the page title are not used within the pages content
This page contains 504 words. That's ok.
25.6% of the text are stop words.
Words from the H1 heading are used in the page content.
The page contains a listing, which indicates a good text layout.
8 paragraphs were found on this page.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 16.53 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
A viewport "width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" is provided.
At least one Apple touch icon is specified.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 10 tags for this page.
Image SEO
(Somewhat important)
1 images have no alt attribute. The content of alt attributes is used by search engines.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
...ontent/uploads/2024/04/Sutro_Logo_2c.pngSutro Logo high resSutro_Logo_2c
...2024/02/Sutro-Logo-white_transparent.pngNo alt attribute providedSutro Logo-white_transparent
...kie-compliance/dist/images/gdpr-logo.pngSutro Biopharma, Inc.
Video URLWidthHeight
...ploads/2024/02/New-Website_Home-page.mp41000
...02/Rotating-ADC-for-website-homepage.mp4

Page structure

H1 heading
(Critically important)
Patients are Sutro’s passion and purpose.
Too many H1 headings
Headings
(Important)
The heading structure is perfect.

Heading structure

Heading levelContent
H1 Patients are Sutro’s passion and purpose.
H1 Next Generation Cancer Therapeutics
H1 Science designed to deliver ENDLESS OPPORTUNITY
H1 Enabling a future where more is POSSIBLE.
H1 INVESTOR RESOURCES
H1 NASDAQ: STRO
H1 Press Releases
H2 Sutro Biopharma Appoints Greg Chow as Chief Financial Officer
H2 Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
H2 Sutro Biopharma to Participate in Upcoming Investor Conferences
Some anchor texts are used more than once.
There are 3 links with a trivial anchor text.
The number of internal links is ok.
None of the anchor texts is too long.
All internal links are not using dynamic parameters.
There are 19 external links on this page.

Found links on this page

LinkAttributesAnchor text
https://www.sutrobio.com/Subdomain IMG-ALT Sutro Logo high res
/about/about-us/Subdomain About Sutro
/leadership/leadership-team/Subdomain Leadership Team
/functional-leadership-team/Subdomain Functional Leadership Team
/leadership/board-of-directors/Subdomain Board of Directors
/leadership/scientific-advisor...Subdomain Scientific Advisory Board
/leadership/clinical-advisory-...Subdomain Clinical Advisory Board
/about/collaborations/Subdomain Collaborations
/corporate-presentation/Subdomain Corporate Presentation
/clinical-trials/Subdomain Clinical Trials
https://www.sutrobio.com/reframe/Subdomain REFRαME
/patient-resources/Subdomain Patient Resources
/commitment-to-patients/Subdomain Commitment To Patients
/compassionate-use-access/Subdomain Compassionate Use Access
/pipeline/Subdomain Pipeline
/technology/antibody-drug-conj...Subdomain iADCs & Antibody-Drug Conjugates
/technology/xpress-cf/Subdomain XpressCF+®
/technology/cgmp-facility/Subdomain cGMP Facility
https://ir.sutrobio.com/External Subdomain Investors
https://ir.sutrobio.com/External Subdomain Overview
https://ir.sutrobio.com/news-e...External Subdomain News & Events
https://ir.sutrobio.com/compan...External Subdomain Company Info
https://ir.sutrobio.com/financ...External Subdomain Financial Info
https://ir.sutrobio.com/stock-...External Subdomain Stock Data
https://ir.sutrobio.com/sec-fi...External Subdomain SEC Filings
https://ir.sutrobio.com/corpor...External Subdomain Governance
https://www.sutrobio.com/news/Subdomain News
/news/news-releases/Subdomain News Releases
/news/presentations/Subdomain Presentation & Publication
/news/events/Subdomain Events
https://ir.sutrobio.com/news-e...External Subdomain Events Audio Replays
https://www.sutrobio.com/careers/Subdomain The Way We Work
/careers/join-our-team/Subdomain Join Our Team
https://www.sutrobio.com/deib/Subdomain DEIB
/environmental-sustainability/Subdomain Sustainability
/careers/internships/Subdomain Internships
/volunteer/Subdomain Philanthropy
/current-volunteer-newsletter/Subdomain Employee Engagement
/contact-us/Subdomain Contact Us
https://youtu.be/v8sbzzTNP1sNew window External WATCH 1:44
/technology/antibody-drug-conj...Subdomain Learn More
https://www.sutrobio.com/deib/Subdomain Text duplicate DEIB
/environmental-sustainability/Subdomain SUSTAINABILITY
/volunteer/Subdomain VOLUNTEER
https://ir.sutrobio.com/news-e...External Subdomain News and Events
https://ir.sutrobio.com/financ...External Subdomain Financial Results
https://ir.sutrobio.com/stock-...External Subdomain Text duplicate Stock Data
/sutro-biopharma-appoints-greg...Subdomain Sutro Biopharma Appoints Greg Chow as Chief Financial Officer
/sutro-biopharma-appoints-greg...Subdomain Trivial anchor text
Read More
/sutro-biopharma-reports-first...Subdomain Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
/sutro-biopharma-reports-first...Subdomain Text duplicate Trivial anchor text
Read More
/sutro-biopharma-to-participat...Subdomain Sutro Biopharma to Participate in Upcoming Investor Conferences
/sutro-biopharma-to-participat...Subdomain Text duplicate Trivial anchor text
Read More
https://www.sutrobio.com/Subdomain No Text
https://twitter.com/SutroBioNew window External Follow
A-TITLE Follow on X
https://www.linkedin.com/compa...New window External Subdomain Text duplicate Follow
A-TITLE Follow on LinkedIn
https://www.threads.net/@sutrobioNew window External Subdomain Text duplicate Follow
A-TITLE Follow on Instagram
https://www.youtube.com/channe...New window External Subdomain Text duplicate Follow
A-TITLE Follow on Youtube
https://www.sutrobio.com/sitemap/Subdomain SITE MAP
/sutro-privacy-policy/New window Subdomain PRIVACY POLICY
https://ir.sutrobio.com/news-e...External Subdomain EMAIL ALERTS
/contact-us/Subdomain CONTACT US
/wp-content/uploads/2024/04/Su...New window Subdomain VISITOR GUIDE
A-TITLE VISITOR GUIDE
https://wordpress.org/plugins/...New window External Powered by GDPR Cookie Compliance

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.sutrobio.com/"
HTTP header
(Important)
The web server version is sent within the HTTP header.
No X-Powered HTTP header is sent.
The web server transmits the web page (HTML) in compressed form.
Performance
(Somewhat important)
The page response time is very slow (2.59 seconds). The response time should be less than 0.4 seconds. Slow websites are bad for search engine bots and also result in bad user experience.
A Content Delivery Network like Google Hosted Libraries can save bandwidth for the JQuery files.
The file size of the HTML document is fine (158 kB).

HTTP Response Header

NameValue
dateThu, 19 Jun 2025 14:22:13 GMT
content-typetext/html; charset=UTF-8
content-length30639
varyAccept-Encoding
serverPagely-ARES/1.21.13
x-gateway-request-id2f6ec34b5f2be2e54fa6b9d1a5a5b0d8
x-content-type-optionsnosniff
x-frame-optionsSAMEORIGIN
referrer-policystrict-origin-when-cross-origin
cache-controlprivate, max-age=0, no-cache
x-pagely-cacheall_caching_disabled
link<https://www.sutrobio.com/wp-json/>; rel="https://api.w.org/", <https://www.sutrobio.com/wp-json/wp/v2/pages/2778>; rel="alternate"; title="JSON"; type="application/json", <https://www.sutrobio.com/>; rel=shortlink
content-encodinggzip
x-gateway-cache-key1750021972.699|standard|https|www.sutrobio.com|||/
x-gateway-cache-statusMISS
x-gateway-skip-cache0
statuscode200
http_versionHTTP/2

External factors

This website has excellent links from other websites.
This page has backlinks from 126 referring domains.
This page has 701 backlinks.
This page has backlinks from 118 different ip addresses.

Links from Wikipedia

No links from Wikipedia were found.

Robots.txt

User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php

Sitemap: https://www.sutrobio.com/wp-sitemap.xml

Similar sites

Search preview

www.sutrobio.com
Sutro Biopharma, Inc. is a public biotechnology company focused on ...
Sutro Biopharma, Inc. is a public biotechnology company headquartered in South San Francisco, California focused on clinical stage drug discovery, development and manufacturing company. Using its integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics for cancer and autoimmune disorders. It focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (I/O) therapeutics, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed primarily against clinically validated targets. Its product candidates include STRO-001 and STRO-002. STRO-001 is an ADC directed against the cancer target CD74, for patients with multiple myeloma and non-Hodgkin lymphoma (NHL). STRO-002 is an ADC directed against folate receptor-alpha (FolRa), for patients with ovarian and endometrial cancers. STRO-001 and STRO-002 are designed and optimized for therapeutic index by placing linker-warheads at specific location...

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Sutro93%Check
Sutro Biopharma80%Check
Biopharma68%Check
Patients62%Check
Inc59%Check
Sutro Biopharma Appoints Greg59%Check
Sutro Biopharma Reports First59%Check
Company58%Check
Drug Discovery58%Check
company focused58%Check
Show more keywords and terms

Automatically check sutrobio.com including all subpages at once!

Try for free
Guaranteed free of charge during trial period.

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions